Polyrizon Ltd. (PLRZ)
1.44
-0.04 (-2.70%)
At close: Jan 14, 2025, 3:59 PM
1.45
1.04%
Pre-market Jan 15, 2025, 08:00 AM EST
undefined% (undefined)
| Bid | 1.42 |
| Market Cap | 6.02M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -5.98 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.45 |
| Volume | 68,370 |
| Avg. Volume (20D) | 3,590,974 |
| Open | 1.48 |
| Previous Close | 1.48 |
| Day's Range | 1.39 - 1.50 |
| 52-Week Range | 0.77 - 4.80 |
| Beta | undefined |
About PLRZ
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel....
Industry Biotechnology
Sector Healthcare
IPO Date Oct 29, 2024
Employees 1
Stock Exchange NASDAQ
Ticker Symbol PLRZ
2 weeks ago ·
Source
+31.71%
Polyrizon shares are trading higher after the comp...
Unlock content with
Pro Subscription
4 weeks ago ·
Source
+213.33%
PolyRizon shares are trading higher after the company announced it secured a GMP partnership with Eurofins CDO Amatsiaquitaine.